Author: Harlan Quill

A dusty patriot with a library card, a suspicious mind, and boots worn from pacing in protest. Raised on Tom Paine and taught by Orwell, Harlan doesn’t salute power — he scrutinizes it. He believes democracy is a rowdy dinner table, not a monologue from the rich. His columns are where forgotten truths resurface, cloaked in cautionary tales and sharpened by wit.
  • CMS Just Padlocked Medicare’s Front Door for Some Medical Supply Companies. Fraud Is Real. So Is Power Creep.

    I spent part of yesterday in that classic American policy workshop: a fluorescent-lit corner of the public library, Federal Register open, printer toner in the air, civic dread on the menu. In my head: a senior with a walker, a kid with braces, a veteran with a CPAP. On screen: Washington trying to stop scams without jamming up care.

    What CMS did (and when)

    CMS imposed a six-month, nationwide moratorium on new Medicare enrollments for certain durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) suppliers, specifically the supplier category it calls medical supply company suppliers. The notice says it takes effect February 27, 2026 and applies across the United States, including territories and the District of Columbia.

    • New businesses whose principal function is furnishing DMEPOS supplies cannot newly enroll under the covered supplier types during the moratorium.
    • Existing enrolled suppliers that need a new initial enrollment (for example, a new practice location that requires separate enrollment) also hit a locked door for six months.
    • Applications received by contractors before the effective date are not supposed to be swept into the ban.

    CMS lists seven affected supplier types, all variations of “medical supply company,” including versions staffed with orthotics, pedorthics, prosthetics, combinations of those, and versions with a registered pharmacist or a respiratory therapist. CMS says it will closely screen applications during the moratorium to stop would-be medical supply companies from slipping in through another category, and it explicitly mentions site visits and online research. It also warns about long reapplication or reenrollment bars and referrals when suppliers submit false or misleading information.

    The Orwell check: “moratorium” is a ban with nicer shoes

    “Moratorium” is the polite noun. “Temporary” is the comforting adjective. Together they read like a sweater you put on so you do not notice the handcuffs.

    Yes, CMS points to authority to impose temporary enrollment moratoria when it determines there is significant potential for fraud, waste, or abuse, and it has to explain itself in a Federal Register notice. That is the civics-textbook version. The lived version is a nationwide enrollment ban, even a narrow one, is a big lever.

    The tradeoff and the liberty ledger

    CMS frames this as a fraud move, not a benefit cut: existing suppliers can keep billing. Other kinds of suppliers that furnish DMEPOS but do not have DMEPOS as their principal function (like pharmacies and hospitals) are not the target. CMS also leaves room for states to decide how, or whether, to mirror a similar moratorium in Medicaid and CHIP.

    Who gains freedom? Beneficiaries and taxpayers, if fewer scams get through. Honest providers, if scammers stop undercutting the market. Who loses freedom? Clean new entrants, for six months, and communities with thin supplier networks that rely on competition and choice. And the system takes on more executive discretion, especially because the notice acknowledges the moratorium can be extended in six-month increments.

    Guardrails worth demanding

    • Publish monthly metrics that justify the moratorium and track collateral damage.
    • Provide a clear, fast appeal and correction path for legitimate suppliers caught in gray zones.
    • Congress should demand oversight review from inspectors general and GAO on whether a nationwide moratorium beats more targeted tools.
    • Put an exit ramp in writing: a public standard for lifting the moratorium, and real specificity for any extension.

    Fraud is a tax on care. But so is unaccountable power. Are we going to demand the guardrails now, or pretend “temporary” always means what it says?

  • EPA Calls It ‘Common Sense.’ The Firehouse Calls It ‘Please Don’t.’

    I read the Federal Register the way some people read horoscopes: not because I believe in fate, but because it tells you what powerful strangers are planning for your week. Most of it is dry, like town-hall carpet and courthouse air. Then you hit a paragraph that smells like bleach, gasoline, and paperwork, which is America’s signature cologne.

    This week’s entry comes with a friendly label and an unfriendly implication. The Environmental Protection Agency has proposed revisions to the Risk Management Program (RMP), the chemical accident prevention requirements under the Clean Air Act. Comments are due April 10, 2026, and EPA has scheduled a virtual public hearing for March 10, 2026. That is not a rumor. That is the docket talking.

    What EPA is proposing

    The proposal carries a civics-class title: the “Common Sense Approach to Chemical Accident Prevention.” It would amend RMP regulations by revising multiple provisions added or strengthened in the 2024 “Safer Communities by Chemical Accident Prevention” rule.

    According to the summary, a lot is on the table for trimming, rescinding, or “realigning,” including safer technology and alternatives analyses, information availability, third-party audits, employee participation, community and emergency responder notification, and requirements related to natural hazards and power loss.

    EPA’s rationale, in plain English

    EPA says the changes would avoid duplicative requirements, better align with OSHA’s Process Safety Management framework, and eliminate burdens where EPA says there is not specific data showing the current standards reduce accidental releases.

    On its RMP overview page, EPA also describes what these plans are for: identifying potential accident effects, prevention steps, and emergency response procedures, and providing valuable information to local responders and communities. So this is not an argument about whether chemical accidents exist. It is an argument about what kind of planning, documentation, and transparency we require before the sirens.

    The Orwell check: “common sense” as a translation device

    Any time Washington baptizes something as “common sense,” I reach for my dictionary. “Common sense” is not a safety standard. It is a mood.

    The Guardian reported that the administration has moved to dismantle parts of the system meant to protect communities from chemical disasters, including curtailing public-facing access to certain chemical hazard information. You can debate security versus transparency. You cannot argue that secrecy makes an accident smaller.

    The liberty ledger, and the tradeoff

    My civil-liberties problem is simple: the “freedom” being expanded looks a lot like freedom from oversight, while the freedom being reduced is the public’s ability to know, prepare, and breathe.

    Supporters will say this is about cost and flexibility, and I will concede that reducing confusion between overlapping EPA and OSHA requirements can reduce confusion, and confusion can be dangerous. But the ledger has to add up.

    Chemical & Engineering News reported EPA projects industry cost savings that could reach $240 million a year, with more than half tied to reduced requirements around safer technologies, plus additional savings tied to employee participation and third-party audits. That is not a rounding error. That is a policy choice about who does the worrying, and when.

    What now

    This is a proposal, not the final rule. Treat the comment period like a real town hall. If EPA believes specific provisions are ineffective, it should show its work with facility-level evidence, not vibes. And Congress should do oversight that includes local emergency managers, union safety reps, fence-line residents, industry engineers, and independent investigators.

    My practical advice: read the proposed rule summary, submit comments if you have standing or expertise, and pressure your representatives to treat chemical safety as infrastructure, not ideology.

    Question for the comments section: if your family lived inside a potential impact zone, what is a fair trade between “regulatory burden” and your right to know, prepare, and breathe?

  • Virginia Tried to Punch a Time Clock Into the Internet. A Judge Hit Pause.

    I have seen this civic script play out in enough town-hall folding chairs to predict the beats: a real problem, a fast bill, and a promise that the new power is narrow and temporary. Then a court walks in like a librarian with a red pen and asks the questions nobody put on the flyer.

    Judge blocks Virginia’s age-check and one-hour limit (for now)

    On Friday, a federal judge blocked Virginia from enforcing its new rule aimed at minors on social media, granting a preliminary injunction in a case brought by NetChoice. The judge found NetChoice was likely to show the law unconstitutionally infringes the free speech rights of adults, children, and the group’s member companies. That is the First Amendment doing its unglamorous job: slowing down sweeping fixes that can sweep up speech along the way.

    This is not a love letter to Big Tech. It is a reminder that when government gets nervous, it reaches for levers. The levers rarely stop at the intended floor.

    What Virginia passed (plain English)

    • Age determination: Social media platforms must use “commercially reasonable methods” to determine whether a user is under 16.
    • Time cap: If a user is a minor, the platform must limit use to one hour per day per service or application.
    • Parental override: A mechanism must allow a parent, via verifiable parental consent, to raise or lower that limit.
    • Use limits on age data: Information collected for age determination cannot be used beyond age determination and “age-appropriate experiences.”
    • No retaliation pricing/quality: Platforms cannot withhold, degrade, lower quality, or increase price because they are not permitted to provide more than the one-hour daily limit.
    • Enforcement rules: The Virginia Attorney General has exclusive enforcement authority, there is a 30-day notice-and-cure window, penalties can run up to $7,500 per violation, and there is no private right of action.

    The Orwell check: “commercially reasonable” is a permission slip

    “Commercially reasonable” is not a method. It is a euphemism that invites methods, and methods at scale tend to mean more collection, more vendors, more retention, and more breach risk. Statutes can limit use on paper, but they do not encrypt databases or stop creep in how phrases like “age-appropriate experiences” get interpreted.

    The liberty ledger, plus the Paine test

    Liberty ledger: minors may gain less compulsive use by default; parents get a lever; the state gains enforcement power over platform design. But the costs are uneven: compliance is architecture, and smaller platforms can get squeezed hardest. And to identify who is under 16, pressure builds to identify everyone, turning speech into something you do after clearing a gate.

    The Paine test: does this expand liberty, or concentrate power? Virginia aims to protect kids, but it leans on an identity-and-access mechanism that can outlive the moment.

    Accountability, not theatrics

    Virginia will keep fighting, and the platforms will keep fighting back. Good. Courts exist to force daylight on the tradeoff. Legislators should rewrite with constitutional limits and real privacy engineering in mind. Watchdogs should demand disclosure about any age-screening vendors and data flows that would have been used. And voters should keep asking: are we solving a child-safety crisis, or installing an ID checkpoint in front of speech and calling it “consumer protection”?

  • Hot Wholesale Inflation, Cold Comfort

    I printed the government’s latest inflation omen like it was a court docket, warm paper in a cold room. It looks neutral until you remember what it can decide. Somewhere between the town hall’s folding chairs and the Federal Reserve’s marble, a single number lands on the table and everyone pretends it is just math.

    It is never just math.

    January PPI ran hot, and the mix matters

    On Friday, the Bureau of Labor Statistics reported that the Producer Price Index for final demand rose 0.5% in January (seasonally adjusted). Over the past 12 months, final demand prices were up 2.9%.

    The split inside that headline is the part people skip at their peril. Final demand services rose 0.8% in January, while final demand goods fell 0.3%. Goods down and services up is the economic equivalent of a library book with a clean cover and missing pages. The sticker says one thing. The story says another.

    Markets had been leaning toward a softer print. Associated Press reported economists expected a smaller monthly increase, and the hotter number revived the familiar chatter about the Fed staying higher for longer.

    Meanwhile, BLS also noted that the aftershocks of a federal government shutdown are still disrupting the basic civic function of publishing data on time, with the next PPI release for February rescheduled for March 18. We have reached the part of the movie where Congress cannot keep the lights on, but the country still expects the gauges to work.

    The tradeoff: One big lever, and households feel it

    The Federal Reserve has only a few levers, and one big one: rates. When inflation data comes in hot, pressure builds to hold off on cuts. That can be prudent. It can also become lazy policy by default, like solving every problem in the civics textbook with the same blunt pencil.

    Higher rates are not abstract. They show up in daily liberty: the freedom to move, to borrow, to start a business, to refinance, to survive a surprise. It is hard to preach personal responsibility to a household whose interest meter runs like a taxi.

    And here is the catch. Producer prices are not consumer prices. PPI is upstream, a picture of what businesses say they are paying or charging at the wholesale level. Upstream pressure can become downstream pain, especially in services, where the line between cost and markup can get conveniently foggy.

    The Orwell check and the Paine test

    The clean word doing dirty work is “inflation.” It can describe a broad rise in prices. It can also function as a hall pass for institutions that want to raise prices first and explain later.

    AP noted that rising margins for retailers and wholesalers may have contributed to the increase, and raised the possibility that tariff-related price hikes could be part of the story. Could. Not proven. Still, the public is being trained to read these reports as permission, not diagnosis.

    The Paine test is simple: does this expand liberty or concentrate power? When a hot PPI becomes nothing but an instruction to “talk rates,” the winners are the actors who can keep prices high behind a headline. The losers are the people on fixed wages, variable hours, and revolving credit. Prices stay up. Rates stay up. Then they are told to be grateful the system is “cooling.”

    Guardrails we are missing, and the ones we can build

    If this report is a warning light, the answer is not to stare at the light and chant “rates.” Congress should start by keeping the government funded so key economic releases are not delayed. Regulators should prioritize transparency in sectors where service prices and fees are sticky and exit is hard, including finance, housing-adjacent services, and concentrated middlemen markets. Antitrust enforcement is not a lefty hobby. It is competition policy that protects the freedom to choose.

    The Fed should keep doing what it does best: publish the reasoning, publish the uncertainties, and resist political arm-twisting from any direction. Independence is not a magic cloak. It is a responsibility that requires sunlight.

    We can handle bad news. What we cannot afford is a system where “inflation” becomes the all-purpose excuse while the bill keeps growing and nobody can find the name of the hand that wrote it. If services and margins are driving the heat, why is the only tool we debate the one that lands hardest on ordinary borrowers?

  • CISA’s Cisco SD-WAN fire drill shows the real federal vulnerability: ‘temporary’ neglect

    I was parked under the library’s fluorescent hum when my phone delivered the modern courthouse bell: an emergency directive about routers. Not romance, not poetry, just the quiet terror of the internet’s plumbing, the stuff nobody thanks until it leaks into everything.

    What happened: an exploited Cisco SD-WAN problem meets a federal deadline

    This week the federal government rediscovered urgency. CISA issued Emergency Directive 26-03, ordering agencies to identify and patch vulnerable Cisco SD-WAN systems after real-world exploitation. FedRAMP followed by alerting cloud providers in its marketplace with a tight compliance tempo: identify what’s in scope, patch, and report back, with status due by 5:00 PM ET on February 27.

    In plain language: Cisco disclosed a critical authentication bypass in Catalyst SD-WAN components, tracked as CVE-2026-20127, and reporting says it has been exploited in the wild. Another SD-WAN flaw, CVE-2022-20775, is also part of the picture, with advisories describing attackers chaining issues to gain deeper access and persistence. CISA added the vulnerabilities to its Known Exploited Vulnerabilities catalog, which is the government’s way of stamping a file folder with: stop debating and start fixing.

    • Inventory what you have.
    • Collect the right logs.
    • Apply Cisco’s updates tied to the directive.
    • Hunt for compromise, then report back.

    SANS NewsBites also describes the quick-turn inventory and patch timelines, including an inventory deadline the night of February 26 and patching by the afternoon of February 27. This is what grown-up cybersecurity looks like: a short fuse and unglamorous work.

    The tradeoff: speed versus certainty, and who eats the overtime

    Emergency directives are necessary. If a max-severity vulnerability is being exploited, you patch. But a two-day remediation window is a stress test for inventory discipline, contractor competence, and whether leaders funded boring maintenance before the building started smoking.

    The Orwell check: “Emergency” is a season, not a day

    In Washington, “emergency” has a long half-life. The language is soothing: “required actions,” “supplemental guidance.” Translation: we are improvising because we never built durable guardrails. And when institutions live in emergency mode, they centralize, monitor more, and retain longer. Some of that is incident response. Some of it becomes habit.

    The liberty ledger and the Paine test

    Liberty ledger: rapid patching lowers the odds that a compromise cascades into citizen-facing systems. But rushed changes can create mistakes, and reporting can widen who receives operational details that matter, and that can leak.

    The Paine test: patching can expand liberty by reducing manipulation of public systems. But if every incident normalizes sweeping monitoring and quiet information sharing, we mint a new civic vulnerability in the name of “temporary” safety.

    Guardrails that should come with the patch

    Strict data minimization for logs and artifacts, transparency after the risk passes, budget honesty for inventory and staffing, and independent oversight by inspectors general sampling compliance reports. Patch the Cisco boxes. Then hold hearings that look like building inspections, not a blame carnival. What guardrail would you demand so the next “emergency” fixes the network without quietly rewiring our rights?

  • The Defense Production Act Is Not an AI Crowbar

    Power behaves predictably under fluorescent light. Put it in a windowless committee room, add a deadline and the word “urgent,” and suddenly “temporary” starts acting like a permanent job title.

    Now swap the binders for a black-box model on classified networks. Same civic story, updated wardrobe.

    The standoff: DPA threats, a Friday deadline, and a contract on the table

    According to reporting by The Washington Post, Defense Secretary Pete Hegseth has told Anthropic to accept Defense Department terms for how its AI can be used by 5:01 p.m. Friday, or face the Defense Production Act being invoked to compel access. The Post also reports the Pentagon floated branding Anthropic a “supply chain risk” and pulling a reported $200 million Defense Department contract if the company does not comply.

    Reuters, citing Axios, reports the same basic dispute: the Pentagon pressing Anthropic to back down on safeguards for military use of its tools, with a Friday deadline looming.

    In a statement released Wednesday, Senators Elizabeth Warren and Andy Kim say they are responding to reports that Hegseth told Anthropic CEO Dario Amodei the Pentagon would use the Defense Production Act against the company if it did not agree to his terms, warning against weaponizing emergency economic powers to strong-arm a private firm.

    Translated into plain English: Anthropic is willing to work with government, but wants limits, specifically around autonomous weapons and domestic mass surveillance. The Pentagon says it will operate within the law and does not want a vendor veto over “lawful” use cases.

    The Orwell check: “all lawful purposes” can be a blank check

    “Lawful” is not the same as “wise,” and it is definitely not the same as “accountable.” Plenty of things were lawful right up until a court, a commission, or a scandal reminded us we had left the Constitution in a coat closet.

    And “supply chain risk” is supposed to mean something sober: adversarial influence, compromised systems, real vulnerability. Turn it into a procurement cudgel for a policy disagreement and you turn a serious label into a political Yelp review. One star: refused to surrender moral agency.

    The Paine test: liberty, or discretion behind classification?

    If the Defense Production Act can be used to force an AI company to relax restrictions on high-risk uses, what expands is not the public’s liberty. What expands is executive discretion at speed, behind classification, with minimal judicial friction.

    That is not inherently villainous. Governments need tools. Militaries need capabilities. China is not waiting for a philosophy seminar. But the American promise is that necessary power is still fenced.

    The liberty ledger: speed today, precedent tomorrow

    • Gain: faster integration of top-tier AI into classified systems, fewer external constraints, cleaner chains of command.
    • Loss: a precedent where emergency economic authority becomes a shortcut around democratic debate on AI, surveillance, and autonomy.

    Private companies are not elected and should not write national security doctrine. But coercing them with the Defense Production Act does not restore democratic control. It swaps one unaccountable actor for another, with the added sheen of federal force.

    Guardrails we need, regardless of who blinks

    The exit ramp is not “Pentagon villain, Anthropic saint.” It is rules that can survive daylight: narrow statutory boundaries on domestic surveillance use cases; clear limits on autonomous targeting with meaningful human control that is defined, not merely promised; written use-case categories approved through a process involving Congress; independent audits by inspectors general with technical capacity; and a whistleblower channel that does not end in professional exile.

    If the Defense Production Act is even being contemplated, Congress should demand a public legal rationale, the specific authority claimed, and why procurement alternatives and negotiated contract terms are insufficient. If the crowbar is that big, the public deserves to see it.

    If the Pentagon gets its way by Friday, what exactly stops the next “urgent” demand from turning AI into the most efficient domestic monitoring tool ever invented?

  • The Ballroom That Built Itself (On a Technicality)

    Washington’s favorite building material is not steel or stone. It’s the procedural dodge. It smells like courthouse air and old paper, like a committee room where the microphones work perfectly until someone asks about money.

    Today’s entry comes with a federal judge’s signature and a construction crane’s shadow: the White House State Ballroom project lives to pour concrete another day.

    What the judge actually did (and didn’t) do

    U.S. District Judge Richard J. Leon denied the National Trust for Historic Preservation’s request for a preliminary injunction that would have paused President Donald Trump’s privately funded, roughly 90,000-square-foot White House State Ballroom project, now underway on the site of the demolished East Wing.

    Important nuance: the court did not “bless” the project on the merits. The ruling is largely procedural. Judge Leon’s message, in plain English, was: you may have serious questions, but you brought the wrong legal vehicle to the toll booth. He invited the plaintiffs to come back with the right one.

    Meanwhile, work continues. The opinion’s factual recap describes the site as active with heavy equipment and a crane. Below-grade work proceeds. Above-grade structural work, according to that same recap, is not anticipated until at least April 2026.

    The procedural hinge: the APA and the “agency” problem

    The National Trust challenged the project using a mix of Administrative Procedure Act claims and constitutional arguments. Judge Leon’s core point was blunt: the Office of the Executive Residence, which is directing the project, is likely not an APA-covered agency. If that’s right, APA review is a dead end.

    He also emphasized that the case, as pled, did not cleanly tee up an ultra vires claim testing whether the President exceeded statutory authority by building without Congress’s express approval and using private funds. He called the issues novel and weighty. Judicial translation: stop making me referee with my hands tied.

    The Orwell check: “privately funded” doing public work

    Underline the euphemism: privately funded. It sounds wholesome, like a bake sale for marble. But when a project sits on federal land, behind federal fences, touching a national symbol, “private” does not mean “no public interest.” It can mean fewer receipts, squishier disclosures, and a lot more trust demanded from the public.

    Even if every dollar is legal, the optics are a slow leak in civic trust. The White House is not a brand sponsorship opportunity. Structure the financing to avoid the usual congressional and administrative friction, and you don’t just change architecture. You change accountability.

    The Paine test, the liberty ledger, and the tradeoff

    • The Paine test: Does this expand liberty or concentrate power? The question is not taste. It’s who decides, under what law, and with what checks.
    • The liberty ledger: The executive gains speed and discretion. Donors, if there are donors, gain proximity and goodwill. The public loses ordinary mechanisms of consent and contest; Congress loses leverage; and when Congress loses leverage, voters do too.
    • The tradeoff: We may get a larger venue and fewer tents on the South Lawn. We pay with oversight and clean accountability, while demolition schedules start to feel like destiny.

    On guardrails, Citizens for Responsibility and Ethics in Washington has argued that some reported contributors should disclose such donations in lobbying filings, and that disclosures have been inconsistent. Agree with CREW’s reading or not, the vulnerability is familiar: when “private” money meets “public” prestige, the rules get slippery.

    Practical closing: Congress should hold oversight hearings on the legal authority and funding structure; demand a clear accounting of donations, contracts, and donor interactions; ask inspectors general and the Government Accountability Office to review procurement, ethics, and any federal resources supporting the project (including security adjustments); and let the courts hear a properly pleaded challenge on the statutory question, not a whack-a-mole match over procedure.

    If a president can rebuild the people’s house with private money and a technicality, what else can get rebuilt the same way before anyone gets a vote?

  • The Supreme Court just carved a quiet exception into the right to counsel

    I can smell a courthouse hallway from ten feet away: old paper, floor wax, and the faint panic of someone realizing their fate is now a paragraph on a docket sheet. That is the air around the Supreme Court’s latest Sixth Amendment ruling, the kind that sounds procedural until it lands on a real person at 2 a.m., when the only thing between you and the state is your lawyer.

    What the Court allowed (and when)

    On February 25, the Supreme Court decided Villarreal v. Texas, a case about a mid-testimony overnight recess. The question: can a trial judge tell a defendant and counsel, you may talk about anything you need, but do not talk about the defendant’s ongoing testimony during the break?

    The Court said yes, as long as the order is qualified and aimed at preventing coaching of testimony, not cutting off counsel entirely.

    Who wrote what (and why it matters)

    Justice Ketanji Brown Jackson wrote the Court’s opinion. Chief Justice John Roberts and Justices Samuel Alito, Sonia Sotomayor, Elena Kagan, Brett Kavanaugh, and Amy Coney Barrett joined it. Justice Alito also wrote separately. Justice Clarence Thomas concurred only in the judgment, joined by Justice Neil Gorsuch.

    Bottom line: the judgment was unanimous, but the reasoning was not one opinion for all nine. That distinction matters. Cracks in reasoning become canyons in the next case. And there is always a next case.

    The facts, in human scale

    David Asa Villarreal took the stand at his Texas murder trial and testified self-defense. An overnight recess interrupted his testimony. The trial judge instructed defense counsel not to manage or coach Villarreal’s ongoing testimony during the break, while making clear Villarreal could still consult counsel on other topics, including sentencing issues and trial strategy.

    Villarreal was convicted and sentenced to 60 years. He argued the restriction violated the Sixth Amendment right to counsel. The Supreme Court affirmed. The Constitution, the Court concluded, does not give a defendant a protected right to confer with counsel about the testimony itself while that testimony is in progress.

    How the Court got there

    The Court stitched together two precedents:

    • Geders v. United States (1976): a judge cannot impose a total overnight ban on communication between a defendant and counsel during a break in testimony.
    • Perry v. Leeke (1989): a judge may stop a testifying defendant from consulting counsel during a brief daytime recess.

    Villarreal lands between them: an overnight recess, but not a total ban. Talk, but do not talk about the testimony for its own sake.

    The tradeoff, the liberty ledger, and the Orwell check

    The tradeoff: We are buying a cleaner record less shaped by late-night coaching. We are paying with something subtler: the practical ability to use counsel while the defendant is most exposed, mid-testimony.

    The liberty ledger: The state gains discretion, and discretion is a kind of power. Defendants lose a slice of practical counsel at the moment they are most exposed.

    The Orwell check: Words like “coaching” and “truth-seeking” are not lies, but they can become incantations: a narrow tool becomes a habit, then a template, then a default.

    A guardrail worth demanding

    If this is the rule, then require adult supervision: any conferral restriction should be read into the record in plain language, with concrete examples of what is allowed.

  • Mortgage rates slip into the fives, and the housing shortage clears its throat

    I was posted up in a municipal library corner where the carpet has seen things and the zoning code sits like a haunted encyclopedia. On the table: a stapled packet from last night’s planning commission meeting, a coffee that tasted like budget season, and one number that makes America lean forward in its folding chair.

    It is not a scandal. It is not a speech. It is a rate.

    Freddie Mac: 30-year mortgage rate hits 5.98%, first sub-6% since 2022

    Freddie Mac’s Primary Mortgage Market Survey puts the average 30-year fixed-rate mortgage at 5.98% for the week ending Feb. 26, down from 6.01% a week earlier. A year ago it averaged 6.76%.

    The 15-year fixed rate was 5.44%, up from 5.35% a week earlier, and down from 5.94% a year ago.

    That 5.98% sounds tiny because it’s a decimal. In housing, decimals are boulders.

    Movement is real. The consequences are messy.

    The Associated Press notes this is the first time the average long-term mortgage rate has slipped below 6% since late 2022, arriving as the spring homebuying season ramps up. AP also points to the 10-year Treasury yield, a key guidepost for mortgage pricing, at about 4.02% midday Thursday, down from roughly 4.07% a week earlier.

    Clean translation: borrowing got a bit cheaper. That can pull buyers off the sidelines, help some owners refinance, and thaw a market that’s been slogging since rates climbed off their pandemic-era lows.

    But housing is not a toaster. You cannot two-day-ship inventory. When demand perks up faster than supply, you do not get affordability. You get a bidding war with better music.

    The tradeoff: lower rates can revive hope, and revive prices

    A lower monthly payment is not the same thing as a lower home price. People shop by payment. When rates dip, buying power rises, and in supply-constrained markets that power often becomes higher offers on the same limited set of listings.

    AP quotes Bright MLS chief economist Lisa Sturtevant saying that if rates stay below 6%, buyers and sellers will start getting back into the market, and the spring season could turn very active. Plausible. Also a warning label.

    Guardrails: do the boring local work, in daylight

    • The Paine test: does a sub-6% moment expand liberty for ordinary people, or just expand leverage for whoever already has the keys?
    • The Orwell check: listen for “emergency” and “stabilization” being used to justify shortcuts that would not survive a calm Tuesday.

    If leaders want this to feel like relief instead of a starter pistol, the follow-up has to be unglamorous: permits, zoning, timelines, and infrastructure. Rates in the fives are a spark. They are not a plan.

    Now that the rate has slipped under 6%, will we legalize enough housing to meet demand, or just fight over the same scarce keys with louder speeches?

  • FDA Opened the Door on a Rare Sinus Disease. Insurers Will Decide Who Walks Through.

    I was in a library once, thumbing through a dusty local-court digest, when it hit me how much of American life is decided by people you never meet using rules you never see. Not a conspiracy. A filing system. In healthcare, the filing system has a co-pay.

    What the FDA did (in public, on the record)

    On February 25, 2026, the Food and Drug Administration approved Dupixent (dupilumab) for adults and children ages 6 and up with allergic fungal rhinosinusitis (AFRS) who have a history of sino-nasal surgery. The FDA calls it the first approval for the condition.

    AFRS is not your garden-variety stuffy-nose season. The FDA describes it as an uncommon, chronic sinus inflammation driven by an allergic reaction to fungi in the sinuses, with thick, sticky mucus. It can include expansion of the sinuses and erosion of surrounding bone, and in severe cases can push toward the eye area or brain. At that point your body stops being a body and starts being a construction site.

    The FDA says the approval was supported by a 52-week study in patients 6 years and older. The agency points to improvements on CT scan scoring for sinus opacification, plus improvements in measures like nasal polyp size, congestion, and sense of smell. It also highlights reduced need for systemic corticosteroids and sinus surgery compared with placebo, and notes the safety profile looked consistent with what is already known for the drug.

    That is the part I can respect: the referee blew the whistle, dated the page, and made a new play legal.

    The tradeoff: progress paid for with paperwork and privacy

    Here is the part that never makes the celebratory press release. In modern American medicine, FDA approval is often the start of the argument, not the end. The real gate swings on coverage, prior authorization, and the fine print of “medical necessity.”

    And those gates are built out of patient data. If you want a high-cost biologic, the system often wants a biography:

    • Imaging
    • Procedure history
    • Medication history
    • Symptoms translated into billing codes

    The approved indication includes a history of sino-nasal surgery. That is clinically meaningful, and also administratively irresistible. It turns your chart into a passport that has to be stamped, photocopied, and re-stamped until you either get the drug or run out of time.

    The Orwell check: when delay wears a lab coat

    Listen to the euphemisms and you can hear the power moving: “utilization management,” “benefits determination,” “step therapy,” “site of care optimization.” Translate it and a lot of it reads: prove you are sick enough, again, to someone who will not meet you.

    The FDA did its job in public. The payer side too often does its job in private, with criteria you only see after you have been denied. That is a due process problem dressed up as a customer-service issue.

    The liberty ledger (who gains, who loses)

    • Patients gain a new, FDA-approved option that could mean fewer surgeries or fewer courses of systemic steroids.
    • Clinicians gain another tool authorized for the problem at hand, which can matter when coverage fights multiply.
    • Insurers and plan administrators gain a clearer box to build policies around, for better or worse.
    • The public gains the possibility of fewer repeat surgeries and complications, and inherits the bill and the temptation to ration through delay.

    The approval expands the menu. The fight is whether the menu becomes a meal or just a laminated tease.

    The Paine test, and the guardrails that would make this real

    The Paine test is simple: does the next phase expand a patient’s practical freedom to get appropriate care, or concentrate power in the hands of whoever controls the paperwork?

    • Transparency: coverage criteria should be public, plain-language, and stable.
    • Speed with teeth: appeals should move on timelines that match a patient’s life; when deadlines are missed, the default should not be “wait longer.”
    • Data minimization: request the narrowest slice of information necessary, not a full medical autobiography.
    • Oversight: treat prior authorization and documentation demands like the quasi-judicial system they are.

    The FDA did the public part. Now the rest of government should do the boring part: rules, audits, enforcement, sunlight. Because if a life-changing therapy exists on paper but not in practice, we have not solved a medical problem. We have just invented a new reason to stand in line.

    So here is my question: should access to an FDA-approved treatment hinge more on clinical need, or on how much private information you are willing to surrender to prove you deserve it?

End of content

End of content